Dr. May Lin Tao, MD

Dr. Tao practices at Keck Hospital of USC in Los Angeles, California, part of University of Southern California.

Dr. Tao's NPI, 1144204249, was assigned on December 1, 2005. Dr. Tao graduated from New York University School of Medicine in 1992. Dr. Tao holds California license G84776.

Dr. Tao's primary practice is Keck Hospital of USC, at 1500 San Pablo Street, Los Angeles, CA 90033 in Los Angeles County. The practice phone is (323) 442-8656.

Dr. Tao's primary practice is Keck Hospital of USC in Los Angeles, California, part of University of Southern California. Dr. Tao is also affiliated with Henry Mayo Newhall Hospital. The medical group on file is USC Care Medical Group. Dmand AI also links Dr. Tao to 4 more medical groups, 2 group practices and clinics, 1 other site and 1 urgent care center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tao practices, 6 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Tao's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Tao is board certified in radiation oncology by the American Board of Radiology. Dr. Tao is licensed in California.

Dmand AI lists anal cancer radiation, brain tumor radiation, breast cancer radiation, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and prostate cancer radiation among the conditions Dr. Tao treats.

CMS data shows 925 Medicare services from Dr. Tao across 12 procedure codes in 2024, for 84 Medicare patients. Medicare paid $69,173 for them. Every service was in an office.

CMS counts 84 Medicare patients who saw Dr. Tao in 2024. The largest group is 65 to 74, with 44 patients. 75% of them have cancer, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 1.92, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tao's median patient age at 71, with 57% women.

In 2024, Dr. Tao wrote 39 Medicare Part D claims for 19 patients. 92% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $154 in total drug cost. In 2020, CMS named 12 claims across 1 drug.

Dr. Tao accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Tao as offering telehealth.

Dmand AI links 10 papers to Dr. Tao, published from 2009 to 2014. The most frequent topics are Breast Neoplasms, Radiation Oncology and Carcinoma, Ductal, Breast. Dr. Tao has published most often in Int J Radiat Oncol Biol Phys. Dr. Tao's most frequent co-authors are Nancy A. Ellerbroek, Karyn A. Goodman, MD and Stella Hetelekidis, MD.

CMS Open Payments shows 32 general payments to Dr. Tao from 15 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 56% of the total. iCAD, Inc paid the most, $1,000.

Dmand AI lists 1 award for Dr. Tao, most recently CMS Stage 1 EHR in 2014.

Dr. Tao graduated from New York University School of Medicine in 1992. Dr. Tao is a member of ASTRO and ASCO.

Dr. Tao is in network with 13 carriers, including Elevance, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 9. Check the plan with the practice before a visit.